Promising E. Coli Vaccine Fizzles in Late-Stage Trial

(MedPage Today) -- An investigational vaccine targeting the Escherichia coli pathogens that commonly cause infections didn't show a protective effect in older adults, the phase III E.mbrace trial found. Among over 17,000 participants ages 60 and...